Broke through top trend line, go longOn the 15 minute chart the price broke through the top trendline and established two more candles firmly above indicating support for a next run. Looking to establish a sizable long position here and hold.
−452.32USD
−34.933MUSD
2.943M
About Panbela Therapeutics, Inc.
Sector
CEO
Jennifer K. Simpson
Headquarters
Waconia
Website
Employees (FY)
7
Founded
2011
ISIN
US69833W3051
Panbela Therapeutics, Inc. engages in the development of disruptive therapeutics for medical purposes. It focuses on development programs that target diseases of the pancreas, including pancreatic cancer and pancreatitis. The firm’s product candidate, SBP-101, is a proprietary polyamine analogue designed to induce polyamine metabolic inhibition (PMI), a metabolic pathway of critical importance in multiple tumor types. The company was founded by Michael T. Cullen, Jr. and Thomas X. Neenan on September 21, 2011 and is headquartered in Waconia, MN.
Playing Field EstablishedThanks to support trend line on the bottom and peak trend line at the top, the range of play for the next while is clearly established. Putting buy and sell orders out at the top and bottom of this range will let you scalp until it breaks out one way or the other. With earnings being only slightly
Panbela Therapeutics confirmed a new zigzag. PBLAWe are dropping and more lower lows are on their way looking at it fractally, momentally. Indicators confirm this stance.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalida
$PBLA: mlCap play - Potential 30-90% upside from today's closesee boxes on chart for Entry, Exit and Stop loss zones. Never chase.
Not for any recommendation, Just an Idea.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
